Jonas, Rahul A.
Yan, Yan Ni
Zhang, Qi
Wang, Ya Xing
Jonas, Jost B.
Funding for this research was provided by:
National Natural Science Foundation of China (81570835)
Article History
Received: 4 February 2021
Accepted: 6 April 2021
First Online: 26 April 2021
Competing interests
: Jost B. Jonas and Rahul A. Jonas: European patent application 16 720 043.5 and US patent application US 2019 0085065 A1: „Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia). Jost B. Jonas: Advisory Board Novartis; Patent holder with Biocompatibles UK Ltd. (Farnham, Surrey, UK) (Title: Treatment of eye diseases using encapsulated cells encoding and secreting neuroprotective factor and/or anti-angiogenic factor; Patent number: 20120263794), Patent application: Agents for the use in the therapeutic or prophylactic treatment of retinal pigment epithelium associated diseases. All other authors declare no competing interests.